Myungin Disgren Capsule 300 mg (Triflusal)

Adult dose

Adults: Administer 600 mg ∼ 900 mg of triflusal daily orally in divided doses during or after meals. This medicine should preferably be taken with meals.

This medication should not be administered to pregnant women or women who may become pregnant. Those with peptic ulcers or a history of peptic ulcers should also avoid use. Individuals allergic to this medication, its ingredients, or salicylic acid derivatives should not take it. This medication should not be used in patients undergoing active bleeding. Patients with kidney or liver function issues should use this medication with caution. Those at risk of bleeding should take care and consult their healthcare provider if necessary. During the course of this medication, gastrointestinal discomfort such as stomach pain, heartburn, indigestion, and nausea may occur; however, taking it with meals or with an antacid may relieve symptoms. Rarely, symptoms such as digestive bleeding, skin rashes, headaches, dizziness, tinnitus, hearing loss, and signs related to blood abnormalities may occur, so if any unusual symptoms persist, consult a physician immediately. Patients with kidney or liver disorders have limited experience with this medication, so caution is required. Additionally, patients at risk of bleeding should be careful as bleeding may increase due to trauma or other pathological conditions. If surgery is planned, this medication should be discontinued at least 7 days prior to surgery after evaluating the risk of bleeding. When used in conjunction with anticoagulants, this medication may increase the effects of anticoagulants, so caution is necessary. Additionally, when combined with hypoglycemic agents, dosage adjustments of the hypoglycemic agents may be required. Women who may become pregnant should avoid using this medication, and its safety and efficacy have not been established in children under 18 years of age, so it is not recommended for use in this age group. In case of overdose, central nervous system symptoms, changes in heart and respiratory systems, and digestive bleeding may occur, and immediate medical attention should be sought for appropriate treatment. This medication must be kept out of reach of children and should not be transferred to another container to maintain safety and quality.

• Abdominal pain
• dysphagia
• heartburn
• indigestion
• nausea
• peptic bleeding
• melena
• conjunctival hemorrhage
• petechiae
• hearing impairment

This medication should be stored in a closed container to protect it from air and moisture. It is best to maintain storage temperatures between 1°C and 30°C.

Appearance

A white hard capsule containing a crystalline powder or white crystalline solid.

Package unit

30 capsules/bottle, 100 capsules/bottle